Medicare Enrolled
Dr. Edgar Willard, M.D.
Cardiovascular Disease · Winter Haven, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Willard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Willard? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Willard
Dr. Edgar Willard is a cardiovascular disease in Winter Haven, FL, with 20 years in practice. Based on federal Medicare data, Dr. Willard performed 60,290 Medicare services across 7,999 unique beneficiaries.
Between the years covered by Open Payments, Dr. Willard received a total of $3,898 from 23 pharmaceutical and/or device companies across 110 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Willard is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 0% volume in FL$ $3,898 industry payments
Medicare Practice Summary
Medicare Utilization ↗60,290
Medicare services
Top 0% in FL for cardiovascular disease
7,999
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,014 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 47,250 | $1 | $2 |
| Office visit, established patient, complex (40-54 min) | 1,228 | $128 | $294 |
| Blood draw (venipuncture) | 1,092 | $8 | $9 |
| Complete blood count (CBC) with differential | 959 | $8 | $16 |
| Natriuretic peptide (heart and blood vessel protein) level | 502 | $38 | $79 |
| Thyroid stimulating hormone (TSH) test | 446 | $16 | $34 |
| Iron level test | 428 | $6 | $13 |
| Ferritin level test (iron stores) | 427 | $13 | $27 |
| Transferrin (iron binding protein) level | 427 | $12 | $26 |
| Comprehensive metabolic blood panel | 413 | $10 | $21 |
| EKG interpretation and report | 405 | $6 | $21 |
| Uric acid level test | 401 | $4 | $9 |
| Electrocardiogram (EKG), 12-lead | 381 | $10 | $51 |
| Thyroxine (thyroid chemical), total | 361 | $7 | $14 |
| Thyroid hormone evaluation | 360 | $6 | $13 |
| Dexamethasone injection (steroid) | 280 | $0 | $0 |
| Hemoglobin A1c test (diabetes monitoring) | 278 | $10 | $19 |
| Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | 244 | $13 | $26 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 244 | $28 | $104 |
| Basic metabolic blood panel | 237 | $8 | $17 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 220 | $20 | $84 |
| Lipid panel (cholesterol and triglycerides) | 211 | $13 | $27 |
| Echocardiogram, transthoracic | 198 | $141 | $612 |
| Regadenoson injection (Lexiscan) for heart stress test | 180 | $44 | $119 |
| Remote pacemaker/defibrillator monitoring, 90 days | 172 | $17 | $74 |
| Vitamin B-12 level test | 162 | $15 | $30 |
| Heart muscle strain imaging | 146 | $27 | $118 |
| Urine culture, bacterial identification | 142 | $8 | $34 |
| Vitamin D level test | 139 | $29 | $59 |
| Prothrombin time test (blood clotting) | 119 | $4 | $9 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 116 | $15 | $45 |
| Remote pacemaker monitoring, 90 days | 102 | $23 | $97 |
| Chest X-ray, 2 views | 97 | $24 | $96 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 92 | $223 | $470 |
| Programming of dual lead pacemaker system | 87 | $55 | $214 |
| Evaluation of implantable heart and blood vessel monitoring system | 81 | $33 | $141 |
| 3d radiographic procedure | 78 | $18 | $69 |
| Infusion, normal saline solution, 250 cc | 76 | $0 | $1 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 74 | $28 | $118 |
| Sed rate test (inflammation marker) | 71 | $3 | $5 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 70 | $47 | $208 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 68 | $8 | $41 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 68 | $18 | $73 |
| Office visit, established patient (30-39 min) | 68 | $65 | $218 |
| Urinalysis with microscopic exam | 66 | $3 | $6 |
| Flu vaccine, high-dose | 65 | $71 | $183 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 65 | $48 | $211 |
| Flu vaccine administration | 65 | $18 | $18 |
| Prostate cancer screening; prostate specific antigen test (psa) | 61 | $19 | $39 |
| Drug injection, under skin or into muscle | 57 | $10 | $42 |
| Liver function blood test panel | 50 | $8 | $16 |
| Automated urinalysis | 49 | $2 | $4 |
| Magnesium level test | 49 | $7 | $13 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 46 | $325 | $1,392 |
| Detection test by immunoassay with direct visual observation for influenza virus | 38 | $16 | $33 |
| Creatinine test (kidney function) | 37 | $5 | $10 |
| Urine microalbumin test (kidney screening) | 36 | $6 | $12 |
| Urine culture, bacterial colony count | 35 | $8 | $34 |
| Urinalysis using microscope | 34 | $3 | $6 |
| Troponin (protein) analysis, quantitative | 33 | $12 | $25 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 33 | $8 | $39 |
| Heart rhythm recording of continous external ekg over 8-15 days | 33 | $6 | $41 |
| Creatine kinase (cardiac enzyme) level, mb fraction only | 32 | $11 | $23 |
| Programming of multiple lead implantable defibrillator system | 29 | $78 | $298 |
| Programming of single lead pacemaker system | 26 | $44 | $181 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 23 | $31 | $138 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 18 | $35 | $90 |
| Office visit, established patient (20-29 min) | 18 | $52 | $150 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 17 | $16 | $33 |
| Ct scan of heart with evaluation of blood vessel calcium | 14 | $49 | $308 |
| Pneumonia vaccine administration | 14 | $30 | $56 |
| CT scan of head/brain, without contrast | 13 | $78 | $341 |
| Bacterial culture, any other source except urine, blood or stool, aerobic | 12 | $8 | $17 |
| Amylase (enzyme) level | 11 | $6 | $13 |
| New patient office visit, complex (60-74 min) | 11 | $135 | $421 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
79.8% high complexity
1.3% medium
18.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,898
Total received (2018-2024)
Avg $557/year across 7 years
Top 46% in FL for cardiovascular disease
23
Companies
110
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,823 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$75 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$260
2023$636
2022$383
2021$572
2020$198
2019$856
2018$992
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$776
Boehringer Ingelheim Pharmaceuticals, Inc.
$498
Boston Scientific Corporation
$295
Abbott Laboratories
$282
Medtronic, Inc.
$266
AstraZeneca Pharmaceuticals LP
$205
Medtronic Vascular, Inc.
$199
Novo Nordisk Inc
$196
Esperion Therapeutics, Inc.
$180
Novartis Pharmaceuticals Corporation
$172
PFIZER INC.
$172
E.R. Squibb & Sons, L.L.C.
$114
PORTOLA PHARMACEUTICALS, INC.
$94
Amgen Inc.
$81
Astellas Pharma US Inc
$75
BOSTON SCIENTIFIC CORPORATION
$67
BIOTRONIK INC.
$61
Amarin Pharma Inc.
$44
Merck Sharp & Dohme LLC
$40
SANOFI-AVENTIS U.S. LLC
$32
Bayer HealthCare Pharmaceuticals Inc.
$18
Baxter Healthcare
$17
Bracco Diagnostics Inc.
$16
Top 3 companies account for 40.3% of total payments
Associated products mentioned in payments ›
ANDEXXA · Allure CRT Pacemaker · Azure · CAMZYOS · COBALT DR MRI SURESCAN · CardioInsight · CoreValve Evolut · Corlanor · ELIQUIS · ENTRESTO · FARXIGA · FreeStyle Libre blood glucose Flash Monitoring System · GENERAL TACHY · GENERAL - THERAPIES · HeartMate 3 Left Ventricular Dev · Hillrom - Carnation Ambulatory Monitor · ISOVUE · JARDIANCE · Kerendia · LATITUDE · LUX DX · LUX-DX · MICRA · MITRACLIP · MOMENTUM · MULTAQ · Mitra Clip system · NEXLETOL · NEXLIZET · Ozempic · Pacemakers · Quadra Allure MP RF CRT Pacemkr · RESONATE · Repatha · Reveal LINQ · Rybelsus · VERQUVO · Vascepa · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $6 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
47
Per 100K population
6.2
County median income
$63,644
Nearest hospital
WINTER HAVEN HOSPITAL
6.0 mi
6.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Willard is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Willard experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Willard performed 47,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Willard receive payments from pharmaceutical companies?
Yes. Dr. Willard received a total of $3,898 from 23 companies across 110 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Willard's costs compare to other cardiovascular diseases in Winter Haven?
Dr. Willard's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Willard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Winter Haven
Browse cardiovascular diseases in Winter Haven ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc..
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology